Ads
-
Related paper
- Paraoxonase 1 and Cardiovascular Risk in Nephrotic Syndrome Patients
- THE CARDIO-PROTECTIVE "PARAOXONASE-1" AS A VALUABLE PROMISING TOOL IN DIAGNOSIS AND/OR ASSESSMENT OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES
- Uric acid and the risk of kidney failure in primary glomerulonephritis patients with nephrotic syndrome: preliminary results of an ongoing single-center prospective study
- ROLE OF PULSE CYCLOPHOSPHAMIDE IN CHILDREN WITH FREQUENTLY RELAPSING NEPHROTIC SYNDROME (FRNS) AND STEROID DEPENDENT NEPHROTIC SYNDROME (SDNS)
- Possible Effects of Paraoxonase 1 Q192r Polymorphism on Serum Paraoxonase Activities of a Group of Type 2 Diabetes Mellitus Patients
- Clinico-investigative assessment and comparison of cardiovascular risk factors in young and elderly patients of acute coronary syndrome
- Atherogenic Dyslipidemia: An Important Risk Factor for Cardiovascular Disease in Metabolic Syndrome and Type 2 Diabetes Mellitus Patients
- Peculiarities of some immunity indicators in patients with nonproliferative forms of chronic glomerulonephritis and nephrotic syndrome
- A study of PT, APTT, fibrinogen and urinary protein-creatinine ratio in paediatric patients with nephrotic syndrome
- ASSOTIATIONS OF PECULIARITIES OF HLA-PHENOTYPE AND THE SENSIBILITY TO THE CORTICOSTEROID TREATMENT IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS WITH NEPHROTIC SYNDROME